RT Journal Article
T1 Outcomes of Isolated Tricuspid Valve Surgery.
A1 Sánchez-Espín, Gemma
A1 Rodríguez-Capitán, Jorge
A1 Otero Forero, Juan José
A1 Becerra Muñoz, Víctor Manuel
A1 Rodríguez Caulo, Emiliano Andrés
A1 Such-Martínez, Miguel
A1 Porras-Martín, Carlos
A1 Villaescusa-Catalán, José Manuel
A1 Mataró-López, María José
A1 Guzón-Rementería, Aranta
A1 Melero-Tejedor, José María
A1 Gutiérrez-Carretero, Encarnación
A1 Jiménez Navarro, Manuel Francisco
AB Isolated tricuspid valve surgery is a rarely performed procedure and traditionally is associated with a bad prognosis, although its clinical outcomes still are little known. The aim of this study was to assess the short- and long-term clinical outcomes obtained at our center after isolated tricuspid valve surgery as treatment for severe tricuspid regurgitation. This retrospective study included 71 consecutive patients with severe tricuspid regurgitation who underwent isolated tricuspid valve surgery between December 1996 and December 2017. Perioperative and long-term mortality, tricuspid valve reoperation, and functional class were analyzed after follow up. Regarding surgery, 7% of patients received a De Vega annuloplasty, 14.1% an annuloplasty ring, 11.3% a mechanical prosthesis, and 67.6% a biological prosthesis. Perioperative mortality was 12.7% and no variable was shown to be predictive of this event. After a median follow up of 45.5 months, long-term mortality was 36.6%, and the multivariate analysis identified atrial fibrillation as the only predictor (Hazard Ratio 3.014, 95% confidence interval 1.06-8.566; P = 0.038). At the end of follow up, 63.6% of survivors had functional class I. Isolated tricuspid valve surgery was infrequent in our center. Perioperative mortality was high, as was long-term mortality. However, a high percentage of survivors were barely symptomatic after follow up.
YR 2020
FD 2020-10-15
LK http://hdl.handle.net/10668/16663
UL http://hdl.handle.net/10668/16663
LA en
DS RISalud
RD Apr 6, 2025